Dynamics at the serine loop underlie differential affinity of cryptochromes for CLOCK:BMAL1 to control circadian timing

  1. Jennifer L Fribourgh
  2. Ashutosh Srivastava
  3. Colby R Sandate
  4. Alicia K Michael
  5. Peter L Hsu
  6. Christin Rakers
  7. Leslee T Nguyen
  8. Megan R Torgrimson
  9. Gian Carlo G Parico
  10. Sarvind Tripathi
  11. NIng Zheng
  12. Gabriel C Lander
  13. Tsuyoshi Hirota
  14. Florence Tama  Is a corresponding author
  15. Carrie L Partch  Is a corresponding author
  1. UCSC, United States
  2. Nagoya University, Japan
  3. Scripps Research Institute, United States
  4. University of Washington, United States
  5. Kyoto University, Japan

Abstract

Mammalian circadian rhythms are generated by a transcription-based feedback loop in which CLOCK:BMAL1 drives transcription of its repressors (PER1/2, CRY1/2), which ultimately interact with CLOCK:BMAL1 to close the feedback loop with ~24-hour periodicity. Here we pinpoint a key difference between CRY1 and CRY2 that underlies their differential strengths as transcriptional repressors. Both cryptochromes bind the BMAL1 transactivation domain similarly to sequester it from coactivators and repress CLOCK:BMAL1 activity. However, we find that CRY1 is recruited with much higher affinity to the PAS domain core of CLOCK:BMAL1, allowing it to serve as a stronger repressor that lengthens circadian period. We discovered a dynamic serine-rich loop adjacent to the secondary pocket in the photolyase homology region (PHR) domain that regulates differential binding of cryptochromes to the PAS domain core of CLOCK:BMAL1. Notably, binding of the co-repressor PER2 remodels the serine loop of CRY2, making it more CRY1-like and enhancing its affinity for CLOCK:BMAL1.

Data availability

Diffraction data have been deposited in PDB under the accession code 6OF7.

The following data sets were generated

Article and author information

Author details

  1. Jennifer L Fribourgh

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Ashutosh Srivastava

    Institute of Transformative Bio-Molecules, Nagoya University, Nagoya, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9820-720X
  3. Colby R Sandate

    Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8758-5931
  4. Alicia K Michael

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Peter L Hsu

    Pharmacology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Christin Rakers

    Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5668-6844
  7. Leslee T Nguyen

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Megan R Torgrimson

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Gian Carlo G Parico

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Sarvind Tripathi

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6959-0577
  11. NIng Zheng

    Pharmacology, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Gabriel C Lander

    Structural Biology, Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4921-1135
  13. Tsuyoshi Hirota

    Institute of Transformative Bio-Molecules, Nagoya University, Nagoya, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4876-3608
  14. Florence Tama

    Institute of Transformative bio-Molecules, Nagoya University, Nagoya, Japan
    For correspondence
    florence.tama@nagoya-u.jp
    Competing interests
    The authors declare that no competing interests exist.
  15. Carrie L Partch

    Chemistry and Biochemistry, UCSC, Santa Cruz, United States
    For correspondence
    cpartch@ucsc.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4677-2861

Funding

National Institutes of Health (R01 GM107069)

  • Carrie L Partch

National Institutes of Health (F31 CA189660)

  • Alicia K Michael

National Institutes of Health (S10 OD021634)

  • Gabriel C Lander

UC Cancer Research Coordinating Committee (CRN-15-380548)

  • Carrie L Partch

National Institutes of Health (DP2 EB020402)

  • Gabriel C Lander

RIKEN (Dynamic Structural Biology Project)

  • Florence Tama

Pew Charitable Trusts (Pew Scholar)

  • Gabriel C Lander

Amgen (Young Investigator)

  • Gabriel C Lander

UC Office of the President (Chancellor's Postdoctoral Fellow)

  • Jennifer L Fribourgh

National Science Foundation (Graduate Research Fellowship)

  • Colby R Sandate

Howard Hughes Medical Institute (Gilliam fellowship)

  • Christin Rakers

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Fribourgh et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,840
    views
  • 482
    downloads
  • 55
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jennifer L Fribourgh
  2. Ashutosh Srivastava
  3. Colby R Sandate
  4. Alicia K Michael
  5. Peter L Hsu
  6. Christin Rakers
  7. Leslee T Nguyen
  8. Megan R Torgrimson
  9. Gian Carlo G Parico
  10. Sarvind Tripathi
  11. NIng Zheng
  12. Gabriel C Lander
  13. Tsuyoshi Hirota
  14. Florence Tama
  15. Carrie L Partch
(2020)
Dynamics at the serine loop underlie differential affinity of cryptochromes for CLOCK:BMAL1 to control circadian timing
eLife 9:e55275.
https://doi.org/10.7554/eLife.55275

Share this article

https://doi.org/10.7554/eLife.55275

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Santi Mestre-Fos, Lucas Ferguson ... Jamie HD Cate
    Research Article

    Stem cell differentiation involves a global increase in protein synthesis to meet the demands of specialized cell types. However, the molecular mechanisms underlying this translational burst and the involvement of initiation factors remains largely unknown. Here, we investigate the role of eukaryotic initiation factor 3 (eIF3) in early differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (NPCs). Using Quick-irCLIP and alternative polyadenylation (APA) Seq, we show eIF3 crosslinks predominantly with 3’ untranslated region (3’-UTR) termini of multiple mRNA isoforms, adjacent to the poly(A) tail. Furthermore, we find that eIF3 engagement at 3’-UTR ends is dependent on polyadenylation. High eIF3 crosslinking at 3’-UTR termini of mRNAs correlates with high translational activity, as determined by ribosome profiling, but not with translational efficiency. The results presented here show that eIF3 engages with 3’-UTR termini of highly translated mRNAs, likely reflecting a general rather than specific regulatory function of eIF3, and supporting a role of mRNA circularization in the mechanisms governing mRNA translation.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Ana Patrícia Graça, Vadim Nikitushkin ... Gerald Lackner
    Research Article

    Mycofactocin is a redox cofactor essential for the alcohol metabolism of mycobacteria. While the biosynthesis of mycofactocin is well established, the gene mftG, which encodes an oxidoreductase of the glucose-methanol-choline superfamily, remained functionally uncharacterized. Here, we show that MftG enzymes are almost exclusively found in genomes containing mycofactocin biosynthetic genes and are present in 75% of organisms harboring these genes. Gene deletion experiments in Mycolicibacterium smegmatis demonstrated a growth defect of the ∆mftG mutant on ethanol as a carbon source, accompanied by an arrest of cell division reminiscent of mild starvation. Investigation of carbon and cofactor metabolism implied a defect in mycofactocin reoxidation. Cell-free enzyme assays and respirometry using isolated cell membranes indicated that MftG acts as a mycofactocin dehydrogenase shuttling electrons toward the respiratory chain. Transcriptomics studies also indicated remodeling of redox metabolism to compensate for a shortage of redox equivalents. In conclusion, this work closes an important knowledge gap concerning the mycofactocin system and adds a new pathway to the intricate web of redox reactions governing the metabolism of mycobacteria.